URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Sharon Elad

Concepts (398)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Hematopoietic Stem Cell Transplantation
25
1997
124
6.680
Why?
Graft vs Host Disease
24
1997
92
6.050
Why?
Mouth Diseases
12
1999
46
6.000
Why?
Diphosphonates
11
2006
40
5.100
Why?
Osteonecrosis
11
2006
23
4.360
Why?
Dental Care for Chronically Ill
12
1997
17
4.180
Why?
Jaw Diseases
9
2006
14
4.000
Why?
Mouth Mucosa
14
1997
43
3.390
Why?
Bone Density Conservation Agents
7
2007
45
3.330
Why?
Immunosuppressive Agents
10
1997
200
2.430
Why?
Antibiotic Prophylaxis
5
2007
34
2.250
Why?
Stomatitis
6
1997
15
2.030
Why?
Budesonide
3
2003
10
1.820
Why?
Jaw
3
2006
10
1.780
Why?
Mouthwashes
6
1999
30
1.760
Why?
Mouth Neoplasms
5
2007
32
1.700
Why?
Middle Aged
40
1996
9461
1.620
Why?
Humans
83
1993
35000
1.600
Why?
Dental Care
6
2002
47
1.410
Why?
Endocarditis, Bacterial
3
2007
29
1.370
Why?
Practice Guidelines as Topic
8
2006
288
1.330
Why?
Mucositis
4
2006
13
1.210
Why?
Transplantation Conditioning
7
2003
33
1.210
Why?
Male
46
1996
18870
1.200
Why?
Osteomyelitis
2
2006
38
1.130
Why?
Female
43
1996
19061
1.080
Why?
American Heart Association
3
2007
22
1.060
Why?
Pilot Projects
10
1997
426
1.030
Why?
Chronic Disease
11
1997
496
0.980
Why?
Carcinoma, Squamous Cell
4
2007
230
0.970
Why?
Adult
35
1993
10906
0.960
Why?
Anesthetics, Local
3
1999
79
0.920
Why?
Phototherapy
2
2008
18
0.890
Why?
Treatment Outcome
17
1996
2487
0.870
Why?
Emergencies
6
2002
78
0.870
Why?
Oral Surgical Procedures
3
2008
8
0.850
Why?
Head and Neck Neoplasms
3
2007
78
0.840
Why?
Administration, Topical
8
1997
88
0.840
Why?
Antineoplastic Agents, Alkylating
2
2005
38
0.820
Why?
Aged
22
2003
6986
0.800
Why?
Paraneoplastic Syndromes
3
2007
13
0.800
Why?
Lymphoma, Non-Hodgkin
2
2009
105
0.800
Why?
Antimicrobial Cationic Peptides
1
2011
11
0.780
Why?
Anticoagulants
3
1996
128
0.780
Why?
Anti-Infective Agents
2
2006
74
0.770
Why?
Platelet Aggregation Inhibitors
2
2008
57
0.770
Why?
Endocarditis
1
2011
10
0.750
Why?
Tacrolimus
3
2003
64
0.750
Why?
Stroke
3
2004
134
0.750
Why?
Drug Discovery
1
2011
11
0.740
Why?
Calcineurin
1
2010
22
0.730
Why?
Cyclophosphamide
2
2006
169
0.720
Why?
Toothache
1
2010
9
0.720
Why?
Anesthesia, Dental
2
2002
13
0.720
Why?
Osteoporosis
2
2007
86
0.710
Why?
Neurotoxicity Syndromes
1
2010
12
0.710
Why?
Immunocompromised Host
2
2007
84
0.710
Why?
Immunoglobulin Light Chains
1
2010
20
0.700
Why?
Facial Pain
2
2007
47
0.700
Why?
Multiple Myeloma
2
2006
73
0.700
Why?
Bone Marrow Transplantation
7
1996
189
0.700
Why?
Anti-Inflammatory Agents
4
2003
109
0.700
Why?
Blood Pressure
3
2002
446
0.700
Why?
Amyloid
1
2010
19
0.700
Why?
Amyloidosis
1
2010
29
0.700
Why?
Immunologic Factors
1
2011
69
0.690
Why?
Neoplasm Recurrence, Local
2
1997
272
0.690
Why?
Heparin, Low-Molecular-Weight
2
1996
15
0.690
Why?
Herpesviridae Infections
1
2010
71
0.690
Why?
Oral Medicine
1
2009
2
0.680
Why?
Stem Cell Transplantation
2
2005
108
0.680
Why?
Patient Acceptance of Health Care
1
2011
100
0.680
Why?
Clinical Governance
1
2009
1
0.660
Why?
Vasoconstrictor Agents
2
2002
30
0.640
Why?
Neoplasms
4
2003
701
0.640
Why?
Opportunistic Infections
1
2008
19
0.630
Why?
Antineoplastic Combined Chemotherapy Protocols
4
1997
409
0.630
Why?
Pemphigus
1
2008
8
0.630
Why?
Diabetes Mellitus, Type 2
3
2006
208
0.620
Why?
Root Planing
1
2008
13
0.620
Why?
Pain
2
2003
363
0.620
Why?
Antiviral Agents
1
2010
181
0.620
Why?
Gingival Hemorrhage
1
2008
34
0.610
Why?
Shock
1
2008
20
0.610
Why?
Gingival Diseases
1
2008
9
0.610
Why?
Leukoplakia, Oral
1
2007
1
0.600
Why?
Periodontitis
1
2008
60
0.600
Why?
Lymphoproliferative Disorders
1
2008
30
0.590
Why?
Precancerous Conditions
1
2007
36
0.590
Why?
Diabetes Complications
1
2008
60
0.590
Why?
Dental Implantation, Endosseous
1
2008
43
0.590
Why?
Double-Blind Method
5
2006
985
0.580
Why?
Antineoplastic Agents
3
2006
598
0.580
Why?
Periodontal Diseases
2
2007
68
0.580
Why?
Myocardial Ischemia
1
2008
112
0.570
Why?
Xerostomia
4
2006
43
0.560
Why?
Hematologic Diseases
1
2007
40
0.560
Why?
Saliva
2
2006
207
0.550
Why?
Terfenadine
1
2006
3
0.550
Why?
Loratadine
1
2006
3
0.550
Why?
Rhinitis
1
2006
7
0.550
Why?
Risk Factors
9
1993
2172
0.540
Why?
Severity of Illness Index
2
2009
878
0.540
Why?
Candidiasis, Oral
1
2006
25
0.540
Why?
Chlorhexidine
1
2006
25
0.540
Why?
Decision Support Techniques
1
2007
70
0.540
Why?
Amphotericin B
1
2006
25
0.540
Why?
Histamine
1
2006
22
0.530
Why?
Gels
1
2006
47
0.530
Why?
Salivary Glands
1
2006
62
0.530
Why?
Young Adult
7
2009
1013
0.520
Why?
Prospective Studies
7
2006
1606
0.520
Why?
Heart Rate
1
2008
449
0.520
Why?
United States
6
2007
2511
0.510
Why?
Antifungal Agents
1
2006
61
0.510
Why?
Research Design
1
2008
326
0.510
Why?
Placebos
3
2006
177
0.490
Why?
Risk Assessment
4
2007
808
0.490
Why?
Smoking
2
2007
387
0.460
Why?
Lidocaine
2
1999
73
0.460
Why?
Infection Control, Dental
1
2003
1
0.450
Why?
Laser Therapy
1
2003
62
0.440
Why?
Ultraviolet Therapy
2
1998
4
0.420
Why?
Adolescent
12
1993
4513
0.420
Why?
Burning Mouth Syndrome
1
2002
5
0.400
Why?
Skin Diseases
1
2003
120
0.390
Why?
Questionnaires
4
2007
942
0.390
Why?
Dental Materials
1
2002
26
0.390
Why?
Drug Hypersensitivity
1
2002
44
0.380
Why?
Electric Stimulation Therapy
2
2011
29
0.380
Why?
Clinical Protocols
3
2007
102
0.370
Why?
Vidarabine
3
2003
27
0.360
Why?
Time Factors
7
1996
3047
0.350
Why?
Carotid Stenosis
3
2004
48
0.350
Why?
Adrenal Cortex Hormones
3
2008
98
0.340
Why?
Myeloablative Agonists
2
2006
6
0.340
Why?
Follow-Up Studies
5
2004
1757
0.330
Why?
Oral Ulcer
2
2008
8
0.330
Why?
Early Diagnosis
2
2007
29
0.320
Why?
Aged, 80 and over
4
2006
2423
0.320
Why?
Ischemic Attack, Transient
3
2002
40
0.310
Why?
Pain Measurement
2
2009
241
0.310
Why?
Statistics, Nonparametric
2
2007
251
0.300
Why?
Transplantation, Homologous
9
1997
261
0.300
Why?
Great Britain
2
2007
95
0.300
Why?
Thalidomide
1
1997
13
0.300
Why?
Sensation Disorders
1
1997
15
0.290
Why?
Mouth
1
1997
54
0.290
Why?
Hepatic Veno-Occlusive Disease
2
1993
2
0.280
Why?
Carotid Artery, Internal
3
2004
28
0.270
Why?
Leukemia, Myeloid, Acute
2
2007
172
0.270
Why?
Peripheral Nervous System Diseases
1
1997
99
0.270
Why?
Child
10
1997
3897
0.270
Why?
Retrospective Studies
4
2004
2167
0.250
Why?
Anesthesia, Local
2
2002
18
0.250
Why?
Cyclosporine
3
2003
61
0.240
Why?
Quality of Life
2
2007
486
0.240
Why?
Peripheral Blood Stem Cell Transplantation
2
2003
20
0.240
Why?
Israel
3
2002
30
0.240
Why?
Case-Control Studies
2
1999
587
0.220
Why?
Busulfan
4
2003
13
0.220
Why?
Glucocorticoids
3
2008
159
0.220
Why?
Cohort Studies
2
2006
912
0.220
Why?
Chi-Square Distribution
2
2011
320
0.220
Why?
Neutropenia
2
2009
61
0.210
Why?
Lingual Nerve
1
2012
8
0.210
Why?
Standard of Care
1
2012
2
0.200
Why?
Therapy, Computer-Assisted
1
2012
12
0.200
Why?
Dental Offices
2
2002
4
0.200
Why?
Bacterial Load
1
2011
2
0.200
Why?
Bacteria, Anaerobic
1
2011
7
0.200
Why?
Bacteria, Aerobic
1
2011
7
0.200
Why?
Hematologic Neoplasms
3
2004
34
0.200
Why?
Staphylococcus
1
2011
11
0.200
Why?
Viridans Streptococci
1
2011
3
0.200
Why?
Gram-Negative Bacteria
1
2011
21
0.200
Why?
Yeasts
1
2011
29
0.190
Why?
Tablets
1
2011
6
0.190
Why?
Streptococcus
1
2011
79
0.190
Why?
Safety
1
2011
99
0.190
Why?
Prosthesis-Related Infections
1
2011
10
0.190
Why?
Lichen Planus, Oral
1
2011
1
0.190
Why?
Stomatitis, Aphthous
1
2011
7
0.190
Why?
Bone Diseases, Metabolic
1
2011
21
0.190
Why?
Tetracyclines
1
2011
6
0.190
Why?
Sjogren's Syndrome
1
2011
20
0.180
Why?
Retinoids
1
2011
24
0.180
Why?
Antibodies, Monoclonal
3
2006
725
0.180
Why?
Drug Design
1
2010
45
0.180
Why?
Dental Pulp
1
2010
15
0.180
Why?
Radiography, Panoramic
3
2004
16
0.180
Why?
Epithelium
1
2011
223
0.180
Why?
Gaucher Disease
1
2010
6
0.180
Why?
Societies, Dental
1
2010
3
0.180
Why?
Drug Administration Schedule
1
2011
362
0.180
Why?
Neoplasms, Second Primary
2
2008
124
0.180
Why?
Wound Healing
2
2008
196
0.170
Why?
Herpes Simplex
1
2010
47
0.170
Why?
Light
1
2010
151
0.170
Why?
Mandibular Diseases
1
2009
17
0.170
Why?
Health Surveys
1
2010
198
0.170
Why?
Myelodysplastic Syndromes
2
2007
129
0.170
Why?
Virus Diseases
1
2010
82
0.170
Why?
Clinical Trials as Topic
2
2006
664
0.170
Why?
Speech Disorders
2
2003
11
0.170
Why?
Antihypertensive Agents
1
2010
77
0.160
Why?
National Institutes of Health (U.S.)
1
2009
60
0.160
Why?
American Hospital Association
1
2008
2
0.160
Why?
Lichenoid Eruptions
1
2008
1
0.160
Why?
Administration, Buccal
1
2008
3
0.160
Why?
Diabetes Mellitus
2
2002
162
0.160
Why?
Statistics as Topic
1
2009
177
0.160
Why?
Dentist's Practice Patterns
1
2008
6
0.160
Why?
Drug Therapy, Combination
2
2006
375
0.160
Why?
Dermatologic Agents
1
2009
24
0.160
Why?
Lymphoma, B-Cell
1
2009
61
0.160
Why?
International Normalized Ratio
1
2008
8
0.160
Why?
Oral Hemorrhage
1
2008
18
0.160
Why?
Carticaine
1
2008
1
0.160
Why?
Mucocele
1
2008
10
0.160
Why?
Guideline Adherence
1
2009
72
0.160
Why?
Logistic Models
1
2011
581
0.160
Why?
Blood Loss, Surgical
1
2008
44
0.160
Why?
Neutrophil Infiltration
1
2008
25
0.160
Why?
Ticlopidine
1
2008
5
0.150
Why?
Osteoporosis, Postmenopausal
1
2008
14
0.150
Why?
Leukemia, Lymphoid
1
2008
63
0.150
Why?
Erythroplasia
1
2007
1
0.150
Why?
Postoperative Hemorrhage
1
2008
19
0.150
Why?
Tooth Extraction
1
2008
33
0.150
Why?
Epinephrine
1
2008
140
0.150
Why?
Jaw, Edentulous, Partially
2
2004
16
0.150
Why?
Confounding Factors (Epidemiology)
1
2008
59
0.150
Why?
Cytodiagnosis
1
2007
33
0.150
Why?
Drug Combinations
1
2008
142
0.150
Why?
Aspirin
1
2008
58
0.150
Why?
World Health Organization
1
2008
37
0.150
Why?
Fatal Outcome
1
2008
101
0.150
Why?
Herpesvirus 4, Human
1
2008
61
0.150
Why?
Infusions, Intravenous
1
2008
139
0.150
Why?
Pain, Referred
1
2007
3
0.150
Why?
Observer Variation
1
2008
137
0.150
Why?
Lymphoma, Follicular
1
2008
54
0.150
Why?
Trigeminal Neuralgia
1
2007
12
0.140
Why?
Bone Marrow
1
2009
282
0.140
Why?
Trigeminal Nerve
1
2007
18
0.140
Why?
Tomography, X-Ray Computed
2
2003
729
0.140
Why?
Diagnosis, Differential
1
2010
855
0.140
Why?
Recombinant Fusion Proteins
1
2009
375
0.140
Why?
Stress, Psychological
1
2010
264
0.140
Why?
Cardiovascular Diseases
1
2010
250
0.140
Why?
Immunosuppression
1
2007
64
0.140
Why?
Histamine H1 Antagonists, Non-Sedating
1
2006
2
0.140
Why?
Necrosis
1
2006
99
0.140
Why?
Fanconi Anemia
1
2006
3
0.140
Why?
Societies, Medical
1
2007
132
0.130
Why?
Gastrointestinal Diseases
1
2006
38
0.130
Why?
Disease Models, Animal
2
2006
908
0.130
Why?
Analysis of Variance
1
2008
705
0.130
Why?
Random Allocation
1
2006
245
0.130
Why?
Health Knowledge, Attitudes, Practice
1
2008
247
0.130
Why?
Haplotypes
1
2005
59
0.130
Why?
Oxygen
1
2008
476
0.120
Why?
Longitudinal Studies
1
2006
372
0.120
Why?
Patient Satisfaction
1
2006
216
0.120
Why?
Postoperative Complications
1
2009
706
0.120
Why?
Bronchiolitis Obliterans
1
2003
5
0.110
Why?
Mediastinal Emphysema
1
2003
9
0.110
Why?
Animals
3
2006
15647
0.110
Why?
Glycoproteins
1
2005
189
0.110
Why?
Retreatment
1
2003
7
0.110
Why?
Ointments
1
2003
9
0.110
Why?
Nutritional Status
1
2003
44
0.110
Why?
Electrocardiography
1
2008
719
0.110
Why?
Pain Management
1
2003
46
0.110
Why?
Peptides
1
2005
277
0.110
Why?
Treatment Failure
1
2003
125
0.110
Why?
Carbon Dioxide
1
2003
201
0.110
Why?
Steroids
1
2003
54
0.100
Why?
Reproducibility of Results
1
2006
859
0.100
Why?
Tongue Diseases
1
2002
2
0.100
Why?
Health Services Needs and Demand
1
2003
93
0.100
Why?
Histamine Release
1
2002
6
0.100
Why?
Endocrine System Diseases
1
2002
13
0.100
Why?
Chest Pain
1
2002
16
0.100
Why?
Postmenopause
1
2002
42
0.100
Why?
Liability, Legal
1
2002
23
0.100
Why?
Inflammation
1
2006
518
0.100
Why?
Respiratory Insufficiency
1
2002
56
0.100
Why?
Syncope
1
2002
94
0.100
Why?
Prevalence
1
2002
530
0.090
Why?
Remission Induction
2
2009
155
0.080
Why?
Antibodies, Monoclonal, Humanized
2
2006
89
0.080
Why?
Fluorescent Antibody Technique
1
1999
287
0.080
Why?
Paresthesia
1
1997
18
0.070
Why?
Hypesthesia
1
1997
12
0.070
Why?
Mastectomy, Segmental
1
1997
24
0.070
Why?
Chemotherapy, Adjuvant
1
1997
85
0.070
Why?
Tretinoin
1
1997
93
0.070
Why?
Pulmonary Veno-Occlusive Disease
1
1997
2
0.070
Why?
Blood Platelet Disorders
1
1996
6
0.070
Why?
Enoxaparin
1
1996
7
0.070
Why?
Hematopoietic Stem Cell Mobilization
2
2003
14
0.070
Why?
Megakaryocytes
1
1996
66
0.070
Why?
Bone Neoplasms
1
1997
180
0.070
Why?
Combined Modality Therapy
2
2005
459
0.070
Why?
Anti-Bacterial Agents
2
2009
432
0.060
Why?
Fibrinolytic Agents
1
1996
59
0.060
Why?
Survival Analysis
2
2005
575
0.060
Why?
Calcinosis
2
2004
57
0.060
Why?
Graft Survival
2
2003
145
0.050
Why?
Secretory Rate
1
2012
40
0.050
Why?
Likelihood Functions
1
2012
52
0.050
Why?
Deglutition Disorders
1
2012
20
0.050
Why?
Child, Preschool
2
2006
2452
0.050
Why?
Selective Estrogen Receptor Modulators
1
2011
9
0.050
Why?
Hormone Replacement Therapy
1
2011
14
0.050
Why?
Calcium, Dietary
1
2011
22
0.050
Why?
Sleep Disorders
1
2012
68
0.050
Why?
Joint Prosthesis
1
2011
20
0.050
Why?
Intention to Treat Analysis
1
2011
8
0.050
Why?
Breast Neoplasms
1
1997
660
0.050
Why?
Bacteremia
1
2011
34
0.050
Why?
Evidence-Based Dentistry
1
2010
6
0.050
Why?
Parathyroid Hormone
1
2011
119
0.050
Why?
RANK Ligand
1
2011
109
0.040
Why?
Bone Density
1
2011
103
0.040
Why?
Vitamin D
1
2011
64
0.040
Why?
Feasibility Studies
2
1996
189
0.040
Why?
Pain, Intractable
1
2010
14
0.040
Why?
Data Collection
1
2011
201
0.040
Why?
Radiation-Protective Agents
1
2010
38
0.040
Why?
Prednisone
1
2010
178
0.040
Why?
Transplantation, Autologous
1
2009
136
0.040
Why?
Chimerism
1
2009
2
0.040
Why?
Angiogenesis Inhibitors
1
2009
19
0.040
Why?
Histocompatibility
1
2009
14
0.040
Why?
Surgical Procedures, Minimally Invasive
1
2009
30
0.040
Why?
Alendronate
1
2009
23
0.040
Why?
Red-Cell Aplasia, Pure
1
2009
9
0.040
Why?
Injections, Intravenous
1
2009
125
0.040
Why?
Terminology as Topic
1
2009
104
0.040
Why?
Dentists
1
2008
16
0.040
Why?
Imidazoles
1
2009
63
0.040
Why?
Immunoglobulins, Intravenous
1
2009
38
0.040
Why?
Antibodies, Monoclonal, Murine-Derived
1
2009
124
0.040
Why?
Radiation Injuries
1
2010
123
0.040
Why?
Administration, Oral
1
2009
302
0.040
Why?
Thrombocytopenia
1
2009
71
0.040
Why?
Dental Caries
1
2010
301
0.040
Why?
Recurrence
1
2009
656
0.040
Why?
Neoadjuvant Therapy
1
2007
30
0.040
Why?
Acute Disease
1
2009
570
0.040
Why?
Histocompatibility Testing
1
2006
37
0.030
Why?
Drug Evaluation
1
2006
98
0.030
Why?
Antilymphocyte Serum
1
2006
26
0.030
Why?
Antibodies, Neoplasm
1
2006
39
0.030
Why?
Curcumin
1
2006
23
0.030
Why?
Medical Oncology
1
2006
40
0.030
Why?
Dietary Supplements
1
2006
43
0.030
Why?
Attitude of Health Personnel
1
2008
267
0.030
Why?
Multivariate Analysis
1
2007
487
0.030
Why?
Primary Prevention
1
2006
52
0.030
Why?
Magnetic Resonance Imaging
1
2011
928
0.030
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2006
89
0.030
Why?
Ultrasonography, Doppler, Duplex
1
2004
20
0.030
Why?
Analgesics
1
2006
108
0.030
Why?
Radiotherapy
1
2006
179
0.030
Why?
Evidence-Based Medicine
1
2006
197
0.030
Why?
Survivors
1
2005
112
0.030
Why?
Endarterectomy, Carotid
1
2004
30
0.030
Why?
Antigens, CD
1
2005
240
0.030
Why?
Nasopharynx
1
2003
46
0.030
Why?
Hematopoiesis
1
2004
128
0.030
Why?
Survival Rate
1
2004
584
0.030
Why?
Hyperthyroidism
1
2002
22
0.030
Why?
Hyperventilation
1
2002
15
0.030
Why?
Adrenal Insufficiency
1
2002
5
0.030
Why?
Ethics, Dental
1
2002
4
0.030
Why?
Consciousness
1
2002
21
0.020
Why?
Central Nervous System Depressants
1
2002
10
0.020
Why?
Monitoring, Intraoperative
1
2002
25
0.020
Why?
Documentation
1
2002
27
0.020
Why?
Angina Pectoris
1
2002
48
0.020
Why?
Patient Selection
1
2003
197
0.020
Why?
Incidence
1
2004
644
0.020
Why?
Pulmonary Embolism
1
2002
57
0.020
Why?
Drug Interactions
1
2002
176
0.020
Why?
Hypoglycemia
1
2002
91
0.020
Why?
Norepinephrine
1
2002
247
0.020
Why?
Respiration
1
2002
176
0.020
Why?
Evaluation Studies as Topic
1
1997
240
0.020
Why?
Myocardial Infarction
1
2002
630
0.020
Why?
Biological Availability
1
1996
39
0.020
Why?
Platelet Count
1
1996
46
0.020
Why?
Injections, Subcutaneous
1
1996
89
0.020
Why?
Half-Life
1
1996
98
0.020
Why?
Blood Platelets
1
1996
271
0.010
Why?

Visualizations


Elad's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department